Kennedy Capital Management, Inc. Harvard Bioscience Inc Transaction History

Kennedy Capital Management, Inc.

  • $4.27 Billion
  • Q3 2024

A detailed history of Kennedy Capital Management, Inc. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 128,536 shares of HBIO stock, worth $278,923. This represents 0.01% of its overall portfolio holdings.

Number of Shares
128,536
Previous 320,146 59.85%
Holding current value
$278,923
Previous $912,000 62.17%
% of portfolio
0.01%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$2.64 - $3.54 $505,850 - $678,299
-191,610 Reduced 59.85%
128,536 $345,000
Q2 2024

Aug 14, 2024
SELL
$2.77 - $4.63 $3,814 - $6,375
-1,377 Reduced 0.43%
320,146 $912,000
Q1 2024

May 15, 2024
SELL
$4.02 - $5.39 $19,143 - $25,667
-4,762 Reduced 1.46%
321,523 $1.36 Million
Q4 2023

Feb 14, 2024
SELL
$4.0 - $5.49 $20,248 - $27,790
-5,062 Reduced 1.53%
326,285 $1.75 Million
Q4 2022

Feb 14, 2023
SELL
$2.12 - $2.86 $108 - $145
-51 Reduced 0.02%
331,347 $917,000
Q3 2022

Nov 14, 2022
SELL
$2.33 - $3.92 $1,195 - $2,010
-513 Reduced 0.15%
331,398 $848,000
Q2 2022

Aug 10, 2022
BUY
$3.28 - $6.42 $1.09 Million - $2.13 Million
331,911 New
331,911 $1.2 Million
Q2 2021

Aug 16, 2021
SELL
$5.44 - $8.4 $3.95 Million - $6.1 Million
-725,974 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$3.91 - $6.99 $987,192 - $1.76 Million
-252,479 Reduced 25.8%
725,974 $3.96 Million
Q4 2020

Feb 12, 2021
SELL
$3.0 - $4.5 $296,697 - $445,045
-98,899 Reduced 9.18%
978,453 $4.2 Million
Q3 2020

Nov 16, 2020
SELL
$2.75 - $4.2 $987,456 - $1.51 Million
-359,075 Reduced 25.0%
1,077,352 $3.24 Million
Q2 2020

Aug 14, 2020
BUY
$2.12 - $3.14 $564,935 - $836,744
266,479 Added 22.78%
1,436,427 $4.45 Million
Q1 2020

May 15, 2020
SELL
$1.42 - $3.29 $555,867 - $1.29 Million
-391,456 Reduced 25.07%
1,169,948 $2.59 Million
Q4 2019

Feb 28, 2020
BUY
$2.45 - $3.25 $1.8 Million - $2.38 Million
733,347 Added 88.56%
1,561,404 $4.76 Million
Q4 2019

Feb 14, 2020
SELL
$2.45 - $3.25 $711,712 - $944,108
-290,495 Reduced 25.97%
828,057 $4.76 Million
Q3 2019

Nov 14, 2019
BUY
$1.59 - $3.47 $1.46 Million - $3.19 Million
918,552 Added 459.28%
1,118,552 $3.44 Million
Q2 2019

Aug 14, 2019
BUY
$1.93 - $4.59 $342,378 - $814,256
177,398 Added 784.88%
200,000 $400,000
Q1 2019

May 13, 2019
BUY
$2.77 - $4.38 $62,607 - $98,996
22,602 New
22,602 $97,000

Others Institutions Holding HBIO

# of Institutions
96
Shares Held
31.5M
Call Options Held
700
Put Options Held
2.1K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $90.4M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email